Filter
354
Text search:
female
drug
users
Featured
Recommendations
20
New Publications
108
Language
Document type
No document type
262
Guidelines
33
Studies & Reports
31
Manuals
12
Strategic & Response Plan
7
Fact sheets
4
Training Material
3
Situation Updates
1
App
1
Countries / Regions
India
27
Ethiopia
14
Nepal
13
Tanzania
12
Kenya
10
Rwanda
10
Sierra Leone
9
South Africa
9
Nigeria
8
Bangladesh
8
Myanmar / Burma
8
Ukraine
7
Western and Central Europe
7
Malawi
6
Asia
6
Global
6
Liberia
5
Uganda
5
Philippines
5
Eastern Europe
5
Zambia
4
Cambodia
4
Namibia
3
Latin America and the Carribbean
3
Albania
3
Tajikistan
3
Ghana
2
Indonesia
2
Sudan
2
Botswana
2
Sri Lanka
2
South–East Asia Region
2
Russia
2
Moldova
2
Georgia
2
Zimbabwe
1
Haiti
1
Pakistan
1
South Sudan
1
Afghanistan
1
Lebanon
1
Turkey
1
Syria
1
China
1
Mozambique
1
Papua New Guinea
1
Eswatini/ Swaziland
1
Hungary
1
Lesotho
1
East and Southern Africa
1
Bhutan
1
Poland
1
Southern Africa
1
Laos
1
Estonia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Authors & Publishers
Publication Years
Category
Countries
157
Women & Child Health
15
Clinical Guidelines
14
Public Health
12
Key Resources
10
Capacity Building
7
Pharmacy & Technologies
1
Toolboxes
HIV
99
Mental Health
25
TB
17
COVID-19
8
Refugee
4
Caregiver
4
NTDs
4
Conflict
3
Ebola & Marburg
2
AMR
2
Pharmacy
2
Cholera
1
Natural Hazards
1
Global Health Education
1
Planetary Health
1
NCDs
1
Malaria
1
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P
...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also re
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
Study Report August 2014
Curatio International Foundation (CIF) and the Association Tanadgoma would like to acknowledge the financial support provided by GFATM under the project “Establishment of evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in t
...
Countries, partners, and donors are committed to the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more than funding; it requires health personnel with the
right mix of skills, and well supported and managed health systems. Mass
...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ...
The term "Programmatic Management of ...
Tokar et al. Health Research Policy and Systems (2019) 17:23 https://doi.org/10.1186/s12961-019-0415-4
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...